IDHIRA: A prospective, multicenter, non-interventional study of ivosidenib in patients with IDH1 R132-mutated cholangiocarcinoma 25. Oktober 2024 Michl M, Hagemeyer N, Grebhardt S, Looss, M, Potthoff K, 2024, AbstractID: AS-DGHO-2024-00336 Posternumber: P1098 Download Progression-free and overall survival of patients with SCLC and ECOG performance status 0-1 – Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-) Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315) Waller, C.F.; Fischer, R.; Reck, M.; Gauler, T.; Christopoulos, P., Bruch, H.-R. Grah, C.; Ludwig, P.; Hipper, A.; Medinger, T.; Tech, S.; Binninger, A.; Jänicke,… Weiterlesen RUBIN: Prospective, intersectoral Real World cohort study for treatment and outcome of patients with non-Hodgkin lymphoma (NHL) in Germany Marschner, P.; Nusch, A.; von der Heyde, E.; Dörfel, S.; Bürkle, D.; Neben, K.; Hamm, N.; Medinger, T.; Härzschel, A.; Dechow, T.; Tamm, I.; Claus,… Weiterlesen